Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
seqWell
AddedFeb 15, 2024
UpdatedJun 18, 2026
seqWell

seqWell

Series A

seqWell revolutionizes DNA sequencing with transformative, scalable NGS library prep technology.

HQ
Beverly, MA, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Founded to revolutionize DNA sequencing, seqWell focuses on transformative NGS library prep technology. Its core mission is to unlock the full potential of modern DNA sequencing instruments through innovative solutions. The company's flagship product, the plexWell™ platform, enables simple and scalable multiplexing of hundreds to thousands of samples, significantly reducing time and cost. seqWell targets various applications including plasmid and amplicon sequencing, gene editing QC, low-pass WGS, microbial sequencing, and viral sequencing.

Notable figures associated with seqWell include key scientists and industry experts who drive innovation in genomic technologies. The company has attracted significant investment from leading venture capital firms, underscoring its potential impact on the genomics field. Key achievements include the successful development and commercialization of multiple library prep kits such as ExpressPlex™ and purePlex™, which have been widely adopted in research and clinical settings. Overall, seqWell's advancements have streamlined DNA sequencing workflows, making high-throughput sequencing more accessible and efficient.

seqWell - Quick Facts

When was seqWell founded?

seqWell was founded in 2014.

Where is seqWell's headquarters located?

seqWell's headquarters is located in Beverly, MA, US.

When was seqWell's last funding round?

seqWell's most recent funding round was for $3.4M (USD) in September 2023.

How much has seqWell raised to-date?

As of Sep 26, 2023, seqWell has raised a total of $21.4M (USD).

How many employees does seqWell have?

seqWell has 49 employees as of Feb 5, 2024.

seqWell - Classification

Industry
  • Hardware
Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • DNA Sequencing
  • Library Prep
Tags
  • Genomics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software